The Environmental Cost Of Production: Will Big Pharma Be On The Hook For API Hazards?
This article was originally published in The Pink Sheet Daily
Executive Summary
India's high-publicity environmental problems may spur a consumer-driven push for environmentally certified pharmaceuticals.
You may also be interested in...
India Plans Taskforce To Deal With Pharmaceutical Environmental Issues
NEW DELHI - The Indian government will soon constitute a taskforce to assess the impact of drug manufacturing on the environment and find amicable solutions, Department of Pharmaceuticals Secretary Ashok Kumar announced Feb. 12 at an industry seminar in New Delhi
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.